BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Froelich A, Osmałek T, Jadach B, Puri V, Michniak-Kohn B. Microemulsion-Based Media in Nose-to-Brain Drug Delivery. Pharmaceutics 2021;13:201. [PMID: 33540856 DOI: 10.3390/pharmaceutics13020201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Mansour M, Nasr M, Ahmed-Farid OAH, Ahmed RF. Intranasal ondansetron microemulsion counteracting the adverse effects of cisplatin: animal study. Pharmacol Rep 2023;75:199-210. [PMID: 36517694 DOI: 10.1007/s43440-022-00435-3] [Reference Citation Analysis]
2 Kar S, Singh SK. Cationic nanoliposomes of carvedilol for intranasal application: In vitro, in vivo and in silico studies. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104178] [Reference Citation Analysis]
3 Nogueira C, Lemos-senna E, da Silva Vieira E, Sampaio TB, Mallmann MP, Oliveira MS, Bernardi LS, Oliveira PR. β-caryophyllene cationic nanoemulsion for intranasal delivery and treatment of epilepsy: development and in vivo evaluation of anticonvulsant activity. J Nanopart Res 2023;25:19. [DOI: 10.1007/s11051-023-05668-8] [Reference Citation Analysis]
4 Dutta D, Setya S, Gautam N, Talegaonkar S. Encapsulation: Microemulsion. Principles of Biomaterials Encapsulation : Volume One 2023. [DOI: 10.1016/b978-0-323-85947-9.00011-x] [Reference Citation Analysis]
5 Gadziński P, Froelich A, Jadach B, Wojtyłko M, Tatarek A, Białek A, Krysztofiak J, Gackowski M, Otto F, Osmałek T. Ionotropic Gelation and Chemical Crosslinking as Methods for Fabrication of Modified-Release Gellan Gum-Based Drug Delivery Systems. Pharmaceutics 2022;15. [PMID: 36678736 DOI: 10.3390/pharmaceutics15010108] [Reference Citation Analysis]
6 Markowicz-Piasecka M, Darłak P, Markiewicz A, Sikora J, Kumar Adla S, Bagina S, Huttunen KM. Current approaches to facilitate improved drug delivery to the central nervous system. Eur J Pharm Biopharm 2022;181:249-62. [PMID: 36372271 DOI: 10.1016/j.ejpb.2022.11.003] [Reference Citation Analysis]
7 Nunes D, Loureiro JA, Pereira MC. Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs. Pharmaceutics 2022;14:2296. [DOI: 10.3390/pharmaceutics14112296] [Reference Citation Analysis]
8 Janani S, Sureshkumar R, Dhanabal S. Perspective Chapter: Microemulsion as a Game Changer to Conquer Cancer with an Emphasis on Herbal Compounds. Surfactants and Detergents - Updates and New Insights 2022. [DOI: 10.5772/intechopen.101479] [Reference Citation Analysis]
9 Zhang YB, Xu D, Bai L, Zhou YM, Zhang H, Cui YL. A Review of Non-Invasive Drug Delivery through Respiratory Routes. Pharmaceutics 2022;14:1974. [PMID: 36145722 DOI: 10.3390/pharmaceutics14091974] [Reference Citation Analysis]
10 Kumar M, Dogra R, Mandal UK. Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations. Journal of Drug Delivery Science and Technology 2022;74:103533. [DOI: 10.1016/j.jddst.2022.103533] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Meirinho S, Rodrigues M, Santos AO, Falcão A, Alves G. Self-Emulsifying Drug Delivery Systems: An Alternative Approach to Improve Brain Bioavailability of Poorly Water-Soluble Drugs through Intranasal Administration. Pharmaceutics 2022;14:1487. [DOI: 10.3390/pharmaceutics14071487] [Reference Citation Analysis]
12 Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro MJ, Burgaletto C, Puglisi G, Bernardini R, Cantarella G. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease. Biomedicines 2022;10:985. [DOI: 10.3390/biomedicines10050985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Al Gailani M, Liu M, Wen J. Ligands for oral delivery of peptides across the blood-brain-barrier. Acta Materia Medica 2022;1. [DOI: 10.15212/amm-2021-0007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 O'Connell RC, Dodd TM, Clingerman SM, Fluharty KL, Coyle J, Stueckle TA, Porter DW, Bowers L, Stefaniak AB, Knepp AK, Derk R, Wolfarth M, Mercer RR, Boots TE, Sriram K, Hubbs AF. Developing a Solution for Nasal and Olfactory Transport of Nanomaterials. Toxicol Pathol 2022;50:329-43. [PMID: 35416103 DOI: 10.1177/01926233221089209] [Reference Citation Analysis]
15 David Jose A, Wu Z, Sunil Thakur S. A comprehensive update of micro- and nanobubbles as theranostics in oncology. Eur J Pharm Biopharm 2022:S0939-6411(22)00029-7. [PMID: 35181491 DOI: 10.1016/j.ejpb.2022.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Moradi F, Dashti N. Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2022;395:133-48. [PMID: 34982185 DOI: 10.1007/s00210-021-02196-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Phongpradist R, Thongchai W, Thongkorn K, Lekawanvijit S, Chittasupho C. Surface Modification of Curcumin Microemulsions by Coupling of KLVFF Peptide: A Prototype for Targeted Bifunctional Microemulsions. Polymers 2022;14:443. [DOI: 10.3390/polym14030443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ma H, Hu Z, Long Y, Cheng L, Zhao C, Shao M. Tanshinone IIA Microemulsion Protects against Cerebral Ischemia Reperfusion Injury via Regulating H3K18ac and H4K8ac In Vivo and In Vitro. Am J Chin Med 2022;50:1845-1868. [DOI: 10.1142/s0192415x22500781] [Reference Citation Analysis]
19 Abbas H, Refai H, El Sayed N, Rashed LA, Mousa MR, Zewail M. Superparamagnetic iron oxide loaded chitosan coated bilosomes for magnetic nose to brain targeting of resveratrol. Int J Pharm 2021;610:121244. [PMID: 34737114 DOI: 10.1016/j.ijpharm.2021.121244] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Wu H, Zhou Y, Wang Y, Tong L, Wang F, Song S, Xu L, Liu B, Yan H, Sun Z. Current State and Future Directions of Intranasal Delivery Route for Central Nervous System Disorders: A Scientometric and Visualization Analysis. Front Pharmacol 2021;12:717192. [PMID: 34322030 DOI: 10.3389/fphar.2021.717192] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
21 Akel H, Ismail R, Katona G, Sabir F, Ambrus R, Csóka I. A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. Int J Pharm 2021;604:120724. [PMID: 34023443 DOI: 10.1016/j.ijpharm.2021.120724] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Vllasaliu D. Non-Invasive Drug Delivery Systems. Pharmaceutics 2021;13:611. [PMID: 33922587 DOI: 10.3390/pharmaceutics13050611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]